BIO-Europe Spring® 2016: CEVEC CEO talks US deals to expand business

April 28, 2016

Frank Ubags, CEO of CEVEC—a company offering industrial scale production of viral vectors for gene therapy firms—speaks with Scrip's Lucie Ellis about the types of deals the platform technology company is seeking and what is coming up for CEVEC in 2016. He also highlights a deal the company is looking to solidify in the coming weeks that will expand its activities in the US.

 


Want to elevate your brand and connect with potential partners? The Cell & Gene Exchange brings together leaders from patient advocacy groups, industry, academia and government to network, exchange ideas and explore partnership opportunities. Learn more here.

Previous Video
BIO-Europe Spring® 2016: Selexis CEO talks licensing, academic partnerships and biosimilars
BIO-Europe Spring® 2016: Selexis CEO talks licensing, academic partnerships and biosimilars

Dr. Igor Fisch, CEO of Selexis SA, a drug discovery and cell-line development services company, speaks to M...

Next Article
Is it possible to create new business out of clinical needs?
Is it possible to create new business out of clinical needs?

Guest post by Björn Varnestig, CEO, Flemingsberg Science   During a period of three years, we let a group o...